https://assets.capyfin.com/instruments/678fdc13234e27009c5d5c26.png avatar
Titan Pharmaceuticals
🇺🇸 NASDAQ:TTNP
•
Sep 30, 2024

Titan Pharmaceuticals Q3 2024 Earnings Report

EPS
-$0.83
Previous year: -$0.4
+107.5%
Gross Profit
$0
Previous year: -$23K
-100.0%
Cash and Equivalents
$3.4M
Previous year: $8.11M
-58.1%
Free Cash Flow
-$693K
Previous year: -$1.84M
-62.2%
Total Assets
$3.6M
Previous year: $10M
-64.0%

Titan Pharmaceuticals Revenue

Titan Pharmaceuticals EPS